Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trialJohn P. Neoptolemos, Markus W. Büchler|The Lancet|2017Cited by 1.9k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer ResectionJohn P. Neoptolemos, for the European Study Group for Pancreatic Cancer, Deborah Stocken et al.|JAMA|2010Cited by 1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyRichard Fox, Daniel H. Palmer, Hassan Malik et al.|The Lancet Oncology|2019Cited by 1.2k
IAP Guidelines for the Surgical Management of Acute PancreatitisWaldemar Uhl, Markus W. B uuml chler, Andrew L. Warshaw et al.|Pancreatology|2002Cited by 774
Clinical and genetic characteristics of hereditary pancreatitis in EuropeNathan Howes, John P. Neoptolemos, Markus M. Lerch et al.|Clinical Gastroenterology and Hepatology|2004Cited by 615